Recurrent Acute Liver Failure as the First Manifestation of ARCN1-Associated Disorder Caused by a Terminal Exon Frameshift Variant
Diagnostics · 25.10.2026 · 16 (21) · 3494
DOI: 10.3390/diagnostics16213494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 25.10.2026. Verfasst von Varvara Shleptsova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, 115478 Moscow, Russia. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
ARCN1-related syndrome (short stature-micrognathia syndrome, SSMG; OMIM #617164) is an autosomal dominant disorder caused by loss-of-function variants in the ARCN1 gene, which encodes the δ-COP (COPD) subunit of the COPI coatomer complex. The condition is classically characterized by intrauterine growth restriction (IUGR), short stature with rhizomelic shortening, microcephaly, micrognathia, facial dysmorphism, and global developmental delay.
Methods
Clinical examination, blood tests and genetic analysis were performed. Whole-exome sequencing and Sanger analysis were conducted, followed by bioinformatics analysis and ACMG-based variant interpretation to identify and characterize the pathogenic variant.
Results
We report a male proband with a previously undescribed variant in the ARCN1 gene, presenting with an atypical phenotype. Notably, the patient lacked the classical syndromic features, including short stature, microcephaly, IUGR, and developmental delay. The predominant clinical manifestation was transient hepatic dysfunction occurring during febrile episodes, which resolved between acute events. On physical examination, rhizomelic shortening and dysmorphic facial features, including mild micrognathia, were found. Overall, identified symptoms were mild in severity, which may be associated with the variant’s location within the gene.
Conclusions
We describe a novel likely pathogenic variant in the ARCN1 gene associated with a mild phenotype of SSMG. This case expands the phenotypic spectrum of ARCN1-related syndrome and highlights the importance of considering this diagnosis in patients with unexplained recurrent liver injury, even in the absence of classical syndromic features.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Centre for Medical Genetics, 115478 Moscow, Russia.
- Federal Research Centre of Nutrition, Biotechnology and Food Safety, 117296 Moscow, Russia.
ORCID-Profile: Ekaterina Nuzhnaya, Evgeny Tatarsky, Philipp Sviridov, Tatiana Strokova, Natalia Semenova
Zitieren
APA
Shleptsova, V., Nuzhnaya, E., Taran, N., Tatarsky, E., Nikolaeva, A., Sviridov, P., Strokova, T., & Semenova, N. (2026). Recurrent Acute Liver Failure as the First Manifestation of ARCN1-Associated Disorder Caused by a Terminal Exon Frameshift Variant. Diagnostics, 16(21), 3494. https://doi.org/10.3390/diagnostics16213494
Vancouver
Shleptsova V, Nuzhnaya E, Taran N, Tatarsky E, Nikolaeva A, Sviridov P, et al. Recurrent Acute Liver Failure as the First Manifestation of ARCN1-Associated Disorder Caused by a Terminal Exon Frameshift Variant. Diagnostics. 2026;16(21):3494. doi:10.3390/diagnostics16213494
BibTeX
@article{Shleptsova2026,
author = {Shleptsova, Varvara and Nuzhnaya, Ekaterina and Taran, Natalia and Tatarsky, Evgeny and Nikolaeva, Alexandra and Sviridov, Philipp and Strokova, Tatiana and Semenova, Natalia},
title = {Recurrent Acute Liver Failure as the First Manifestation of ARCN1-Associated Disorder Caused by a Terminal Exon Frameshift Variant},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {21},
pages = {3494},
doi = {10.3390/diagnostics16213494}
}
EUVIMED